We tested the hypothesis that atrioventricular (AV) junction ablation in conjunction biventricular pacing [cardiac resynchronization (CRT)] pacing is superior to pharmacological rate-control therapy in reducing heart failure (HF) and hospitalization in patients with permanent atrial fibrillation (AF) and narrow QRS.
A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS / Brignole, Michele; Pokushalov, Evgeny; Pentimalli, Francesco; Palmisano, Pietro; Chieffo, Enrico; Occhetta, Eraldo; Quartieri, Fabio; Calò, Leonardo; Ungar, Andrea; Mont, Lluis. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 39:(2018), pp. 3999-4008. [10.1093/eurheartj/ehy555]
A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS
Ungar, Andrea;
2018
Abstract
We tested the hypothesis that atrioventricular (AV) junction ablation in conjunction biventricular pacing [cardiac resynchronization (CRT)] pacing is superior to pharmacological rate-control therapy in reducing heart failure (HF) and hospitalization in patients with permanent atrial fibrillation (AF) and narrow QRS.
| File | Dimensione | Formato | |
|---|---|---|---|
|
apaf-crt.pdf
accesso aperto
Descrizione: pdf
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
777.13 kB
Formato
Adobe PDF
|
777.13 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
